Carcinoid tumors of the duodenum

被引:86
作者
Mullen, JT [1 ]
Wang, HM [1 ]
Yao, JC [1 ]
Lee, JH [1 ]
Perrier, ND [1 ]
Pisters, PWT [1 ]
Lee, JE [1 ]
Evans, DB [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
关键词
D O I
10.1016/j.surg.2005.09.016
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Carcinoid tumors of the duodenum are rare, and their natural history has not been defined. Consequently, there is no consensus on the optimal extent of surgical treatment. Methods. The authors reviewed the records of all patients with primary carcinoid tumors of the duodenum treated at their institution from 1969 through 2004. Patients with primary periampullary tumors and gastrinomas were excluded. Results. Twenty-four patients had a pathologic diagnosis of duodenal carcinoid tumor. The majority (89%) of tumors' measured less than 2 cm in diameter, and most (85%) were limited to the mucosa or submucosa. Lymph node metastases were identified in the surgical specimen in 7 (54%) of 13 patients in whom lymph nodes were examined, including 2 patients with tumors smaller than I cm and limited to the submucosa. A I a mean follow-up of 46 months, the disease-specific survival rate was 100%, and only 2 patients have had recurrences in regional lymph nodes. No patient has had distant metastases or the carcinoid syndrome. Conclusions. Carcinoid tumors of the duodenum are indolent. The presence of regional lymph node metastases cannot be predicted reliably on the basis of tumor size or depth of invasion, and their impact on survival is uncertain.
引用
收藏
页码:971 / 977
页数:7
相关论文
共 24 条
  • [1] [Anonymous], 1887, VIRCHOWS ARCH
  • [2] BURKE AP, 1990, ARCH PATHOL LAB MED, V114, P700
  • [3] Ampullary carcinoid tumors: Rationale for an aggressive surgical approach
    Clements, WM
    Martin, SP
    Stemmerman, G
    Lowy, AM
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2003, 7 (06) : 773 - 776
  • [4] DOES THE METHOD OF MANAGEMENT OF PAPILLARY THYROID-CARCINOMA MAKE A DIFFERENCE IN OUTCOME
    DEGROOT, LJ
    KAPLAN, EL
    STRAUS, FH
    SHUKLA, MS
    [J]. WORLD JOURNAL OF SURGERY, 1994, 18 (01) : 123 - 130
  • [5] SURGERY IN ZOLLINGER-ELLISON SYNDROME ALTERS THE NATURAL-HISTORY OF GASTRINOMA
    FRAKER, DL
    NORTON, JA
    ALEXANDER, HR
    VENZON, DJ
    JENSEN, RT
    [J]. ANNALS OF SURGERY, 1994, 220 (03) : 320 - 330
  • [6] Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors
    Kidd, M
    Eick, G
    Shapiro, MD
    Camp, RL
    Mane, SM
    Modlin, IM
    [J]. CANCER, 2005, 103 (02) : 229 - 236
  • [7] Predicting outcome and directing therapy for papillary thyroid carcinoma
    Kim, S
    Wei, JP
    Braveman, JM
    Brams, DM
    [J]. ARCHIVES OF SURGERY, 2004, 139 (04) : 390 - 393
  • [8] Foregut carcinoids: A clinical and biochemical analysis
    Kirshbom, PM
    Kherani, AR
    Onaitis, MW
    Hata, A
    Kehoe, TE
    Feldman, C
    Feldman, JM
    Tyler, DS
    [J]. SURGERY, 1999, 126 (06) : 1105 - 1110
  • [9] Updated population-based review of carcinoid tumors
    Maggard, MA
    O'Connell, JB
    Ko, CY
    [J]. ANNALS OF SURGERY, 2004, 240 (01) : 117 - 122
  • [10] Makhlouf HR, 1999, CANCER, V85, P1241, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1241::AID-CNCR5>3.0.CO